Scientists and researchers are excited over the latest completion of a Phase II clinical trial for those suffering from mesothelioma – an incurable asbestos-caused cancer that has a median survival of only 9 to 12 months. The LUME-Meso Phase II trial for patients with malignant pleural mesothelioma showed a slight[…]
From the blog
Lack of Treatment Responses for Mesothelioma, Proteins Combat Metastasis
Mesothelioma is an incredibly difficult cancer to treat. Its late stage diagnosis coupled with its aggressive nature leaves victims without very much time to combat this fatal cancer. There are a variety of treatment options available to those suffering from mesothelioma, even though there is no cure. Surgery Radiation Chemotherapy[…]
Lung-Sparing Surgery Dramatically Improves Prognosis for Mesothelioma Patients
Those suffering from mesothelioma know that the prognosis is grim. The average life expectancy for someone who is recently diagnosed is only eight months. Chemotherapy is the standard treatment for mesothelioma, but in most cases, the cancer is too far advanced for chemotherapy to be effective. Surgery for mesothelioma is[…]
Chemical Components In Peppers and Sea Cucumbers May Combat Mesothelioma
Mesothelioma is difficult to treat for a number of reasons. The long latency period before initial diagnosis means that the cancer is typically in advanced stages by the time it is discovered. A built-up resistance to common cancer treatments also makes it difficult for treatment to have a positive effect[…]
Positive Response for Immunotherapy Treatment KEYTRUDA ®
Scientists and researchers from Merck announced an update on their findings for the Phase 1b KEYNOTE-28 study that involves the investigation of the immunotherapy treatment called KEYTRUDA ® (pembrolizumab). The purpose of this study was to evaluate the safety, tolerability, and the anti-tumor activity of KEYTRUDA ® and focused on[…]
The First Case of Pulmonary Asbestosis
Asbestosis, a severe and life threatening disease, is directly linked to the inhalation of asbestos fibers. In asbestosis, these fibers make their way to one’s lungs and become embedded in the inner tissue. The tissue then scars causing “fibrosis.” Once the tissue begins to scar, it then starts to harden[…]
Ptac2S Potentially More Effective Than Cisplatin When Fighting Mesothelioma
Malignant Pleural Mesothelioma (MPM) is a rare, aggressive asbestos –related cancer that has a poor survival rate due to the fact that the cancer is hard to detect early, and once detected, has usually spread and is hard to control. Surgery is typically an effective option for removing cancerous cells,[…]
Properties in Red Wine Could Help Fight Mesothelioma
Combining different types of treatment when it comes to treating mesothelioma is common because of how aggressive the cancer can be. While some treatments do prove to be effective, the overall prognosis of an individual with this asbestos-related cancer remains dim. A recent study done in Korea carefully evaluated the[…]
The Introduction of the Alan Reinstein Ban Asbestos Now Act of 2016, S.3427
The Alan Reinstein Ban Asbestos Now Act of 2016 S.3427 was introduced to the Senate on September 28, 2016. Supported by Senator Barbara Boxer, this bill was read and referred to the Committee on Environment and Public Works. Its purpose is to amend the Toxic Substances Control Act (TSCA) to[…]
Asbestos Exposure – Can We Really Control It?
Asbestos is typically thought of as a substance that is no longer in use anymore because it is a well-known carcinogen. Asbestos is fire resistant, strong, cheap, abundant, and absorbs sound. It is no wonder it rose to popularity throughout the 20th century since it was so versatile. While asbestos[…]
